Ozempic Lawsuits

Ozempic’s Rise and Risks

Approved by the FDA in 2017 for type 2 diabetes, Ozempic—known scientifically as semaglutide—quickly proved its worth. It boosts insulin production and slows digestion which stabilizes blood sugar effectively. The issue is that Ozempic’s knack for dampening appetite soon drew attention far beyond diabetes patients. By 2025, off-label use for weight loss had exploded, driven by social media buzz and celebrity transformations. Novo Nordisk capitalized on this trend with Wegovy, a higher-dose version of the same drug, marketed specifically for shedding pounds.

Popularity soared, but so did reports of trouble. Patients started facing issues far worse than the mild nausea or tiredness mentioned on the label. Conditions like gastroparesis—where the stomach essentially stops working—along with pancreatitis, gallbladder problems, kidney damage, blood clots, and even sudden blindness cropped up repeatedly. Some ended up in hospitals. Others needed surgery. And a few now live with lasting damage, their entire lives uprooted and changed. Were these dangers spelled out clearly enough to users and doctors? That question pulls personal injury law into the spotlight.

The Real Toll on People

Ozempic’s side effects hit hard, and the impact goes beyond numbers—it changes lives. Picture a woman from Louisiana who took the drug and wound up with gastroparesis so bad she couldn’t stop vomiting, lost teeth, and racked up hospital visits. Another person from KY ended up with a stomach condition that left her unable to work, which is an employment lawsuit in the making. In PA over 1,400 cases have been compiled into a federal lawsuit, all with stories like these. The Law Office of Jason Tenenbaum is also considering compiling cases of those who have been injured by Ozempic in a class action lawsuit.

Take gastroparesis as an example: it stalls the stomach’s ability to move food along, leading to relentless nausea, bloating, and sharp pain. Dehydration sets in fast, and it’s a far cry from the minor upset anyone might shrug off. Then there’s the rarer but chilling risk of sudden vision loss tied to a condition called NAION, where blood flow to the optic nerve cuts off, leaving permanent damage. Studies in 2024 flagged a stark jump in this risk for Ozempic users—up to seven times higher than expected.

The damage doesn’t stop at the body and other aspects of Ozempic users lives can be affected. Medical bills pile up quickly. If the person ends up with a disability, their job and/or workplace may be affected and in NY reasonable accommodations need to be made for a permanently or even temporarily disabled person. The Law Office of Jason Tenenbaum, P.C. sees these not just as side effects, but as injuries that might trace back to negligence—or at least a failure to warn—by Novo Nordisk.

Ozempic Personal Injury

With the rise of Ozempic injuries likely going to rise since it is becoming more widely available, personal injury lawsuits are going to also become more prevalent. With Ozempic, the focus often lands on product liability—a slice of this field that tackles dangerous goods. Claims can hinge on a few angles: a flaw in the drug’s design, a slip-up in how it’s made, or a lack of clear warnings about risks. Most lawsuits against Ozempic zero in on that last one, arguing Novo Nordisk either knew about serious side effects or should have, yet didn’t tell patients or doctors enough.

The warning issue carries weight as far as an Ozempic lawsuit goes. Many plaintiffs say the drug’s label brushed off or skipped over risks like gastroparesis and vision loss, even as evidence piled up. Early packaging mentioned stomach troubles but nothing hinted at full-on paralysis until lawsuits and federal pressure forced a closer look. The vision problem surfaced in studies years after the drug hit shelves—an apparent lag in keeping tabs on safety. If Novo Nordisk prioritized sales over being upfront and pushed Ozempic for weight loss without digging into these horrible side effects, they could be held accountable for negligence and anyone tied to a lawsuit could be substantially compensated.

Other Considerations

Other legal paths cross into this mess too. A doctor prescribing Ozempic off-label without laying out the downsides might face a malpractice claim. With the rise of “convenient” GLP-1 medication being prescribed through online medication companies like Hims & Hers (who just spent major money on the recent Super Bowl’s advertising) these cases could become more and more common.

False advertising could also play a role if the company overhyped benefits and glossed over dangers in its marketing, similar to how in a drug commercial all the side affects are rattled off quickly while you are lulled by nice images of people smiling and living their best life. The Law Office of Jason Tenenbaum, P.C. digs into each case, picking the best angle to chase justice from whoever dropped the ball.

Lawsuits in 2025

The legal fight over Ozempic is picking up steam. A big batch of lawsuits—over 1,400 so far—sits in Pennsylvania’s federal court, roping in Novo Nordisk and Eli Lilly, which makes similar drugs like Mounjaro. Lawyers and legal experts expect that number could climb to 10,000 as more people speak up and more people begin to use the drug for vain purposes. No big payouts have landed yet, but test trials later this year will set the stage for what’s next.

How much these cases settle for depends on the amount of harm done to the individual. Stomach paralysis or a lost gallbladder could land a client between $400,000 and $700,000 respectively, going by past drug lawsuits. If someone dies from complications families could see $2 million or more, a small compensation for the loss of a loved one. The math hinges on solid proof tying Ozempic to the injury, how long the person took it, and the hit to their finances and well-being—think doctor bills, missed paychecks, and plain old misery.

Novo Nordisk of course pushed back, saying diabetes itself often causes these problems. But research keeps stacking up against them—like a 2024 study showing a massive spike in blood clot risks with semaglutide. The Law Office of Jason Tenenbaum uses that kind of data as well as expert input to punch holes in corporate excuses.

Starting an Ozempic Lawsuit

Anyone hurt by Ozempic and thinking about a lawsuit needs to act quickly and begin working with legal counsel as soon as possible. A solid case starts with proof—prescription records, a clear diagnosis tied to the drug, and signs Novo Nordisk didn’t warn enough. Time limits vary by state: New York gives three years from the injury or when it’s discovered, while California cuts it to two. Not meeting deadlines is a case and claim killer so be sure to select an experienced attorney who is confident in getting in all the appropriate submissions in time.

Evidence matters a lot in personal injury cases. Gather medical files, receipts, and notes about what happened—those details build a strong story. A skilled lawyer can then file the claim and handling the back-and-forth with the company. The Law Office of Jason Tenenbaum, P.C. walks clients through it all, from the first chat to a courtroom showdown if it comes to that, keeping every piece in place.

Why The Law Office of Jason Tenenbaum, P.C. Stands Out

Ozempic’s fallout isn’t just a health scare—it’s a legal, financial, and emotional burden. At The Law Office of Jason Tenenbaum, we bring years of know-how in personal injury and drug cases to the table, ready to take on Novo Nordisk or another other dangerous drug peddling company and win compensation that covers your losses. Free consultations mean no risk in reaching out, and a contingency setup—no payment unless the case wins—keeps it straightforward. Every client gets an approach that fits their situation.